Levothyroxine Sodium Tablets USP, 150 mcg recall — FDA D-0120-2025
Superpotent Drug and Subpotent Drug: potency failures obtained
Overview of recall records associated with Viatris Inc., including dates, categories and classifications where available.
Classification mix: Class II: 14, Class III: 1, Class I: 1.
Superpotent Drug and Subpotent Drug: potency failures obtained
Superpotent Drug and Subpotent Drug: potency failures obtained
Superpotent Drug and Subpotent Drug: potency failures obtained
Superpotent Drug and Subpotent Drug: potency failures obtained
Superpotent Drug and Subpotent Drug: potency failures obtained
Superpotent Drug and Subpotent Drug: potency failures obtained
Superpotent Drug and Subpotent Drug: potency failures obtained
Superpotent Drug and Subpotent Drug: potency failures obtained
Superpotent Drug and Subpotent Drug: potency failures obtained
Superpotent Drug and Subpotent Drug: potency failures obtained
Superpotent Drug and Subpotent Drug: potency failures obtained
Failed Tablet/Capsule Specifications: There is a potential for the imprint, M 122, to be missing on some tablets.
CGMP Deviations: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or…
Presence of Particulate Matter: Product complaint for the presence of glass particles in a syringe.
Presence of Particulate Matter: A complaint was received for the presence of a single strand of hair in one vial.
Failed Dissolution Specifications: low out of specification results for dissolution.
This page summarizes recall records in which the official source identifies Viatris Inc. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.